Longer hydroxyurea administration prior to imatinib mesylate is risk factor for unsuccessful major molecular response in chronic-phase chronic myeloid leukemia: Possibility of P-glycoprotein role
Research output: Contribution to journal › Article › peer-review
6Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Longer hydroxyurea administration prior to imatinib mesylate is risk factor for unsuccessful major molecular response in chronic-phase chronic myeloid leukemia: Possibility of P-glycoprotein role'. Together they form a unique fingerprint.